BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 37212067)

  • 1. Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models.
    Pugliese A; Holland SH; Rodolico C; Lochmüller H; Spendiff S
    J Neuromuscul Dis; 2023; 10(5):731-759. PubMed ID: 37212067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Electrophysiology of Presynaptic Congenital Myasthenic Syndromes With and Without Facilitation: From Electrodiagnostic Findings to Molecular Mechanisms.
    Nicolau S; Milone M
    Front Neurol; 2019; 10():257. PubMed ID: 30941097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
    Andreux F; Hantaï D; Eymard B
    Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myasthenic syndromes.
    Eymard B; Hantaï D; Estournet B
    Handb Clin Neurol; 2013; 113():1469-80. PubMed ID: 23622369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes.
    Webster RG
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29710836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome.
    Donkervoort S; Mohassel P; Laugwitz L; Zaki MS; Kamsteeg EJ; Maroofian R; Chao KR; Verschuuren-Bemelmans CC; Horber V; Fock AJM; McCarty RM; Jain MS; Biancavilla V; McMacken G; Nalls M; Voermans NC; Elbendary HM; Snyder M; Cai C; Lehky TJ; Stanley V; Iannaccone ST; Foley AR; Lochmüller H; Gleeson J; Houlden H; Haack TB; Horvath R; Bönnemann CG
    Am J Med Genet A; 2020 Oct; 182(10):2272-2283. PubMed ID: 32776697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea.
    Bauché S; O'Regan S; Azuma Y; Laffargue F; McMacken G; Sternberg D; Brochier G; Buon C; Bouzidi N; Topf A; Lacène E; Remerand G; Beaufrere AM; Pebrel-Richard C; Thevenon J; El Chehadeh-Djebbar S; Faivre L; Duffourd Y; Ricci F; Mongini T; Fiorillo C; Astrea G; Burloiu CM; Butoianu N; Sandu C; Servais L; Bonne G; Nelson I; Desguerre I; Nougues MC; Bœuf B; Romero N; Laporte J; Boland A; Lechner D; Deleuze JF; Fontaine B; Strochlic L; Lochmuller H; Eymard B; Mayer M; Nicole S
    Am J Hum Genet; 2016 Sep; 99(3):753-761. PubMed ID: 27569547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myasthenic syndromes: genetic defects of the neuromuscular junction.
    Ohno K; Engel AG
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):78-88. PubMed ID: 11898587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction.
    Engel AG; Ohno K; Shen XM; Sine SM
    Ann N Y Acad Sci; 2003 Sep; 998():138-60. PubMed ID: 14592871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia.
    Webster RG; Vanhaesebrouck AE; Maxwell SE; Cossins JA; Liu W; Ueta R; Yamanashi Y; Beeson DMW
    Hum Mol Genet; 2020 Aug; 29(14):2325-2336. PubMed ID: 32543656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motoneuron-specific loss of VAChT mimics neuromuscular defects seen in congenital myasthenic syndrome.
    Joviano-Santos JV; Kljakic O; Magalhães-Gomes MPS; Valadão PAC; de Oliveira LR; Prado MAM; Prado VF; Guatimosim C
    FEBS J; 2021 Sep; 288(18):5331-5349. PubMed ID: 33730374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations.
    Rodríguez Cruz PM; Cossins J; Estephan EP; Munell F; Selby K; Hirano M; Maroofin R; Mehrjardi MYV; Chow G; Carr A; Manzur A; Robb S; Munot P; Wei Liu W; Banka S; Fraser H; De Goede C; Zanoteli E; Conti Reed U; Sage A; Gratacos M; Macaya A; Dusl M; Senderek J; Töpf A; Hofer M; Knight R; Ramdas S; Jayawant S; Lochmüller H; Palace J; Beeson D
    Brain; 2019 Jun; 142(6):1547-1560. PubMed ID: 31081514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy.
    Nicole S; Chaouch A; Torbergsen T; Bauché S; de Bruyckere E; Fontenille MJ; Horn MA; van Ghelue M; Løseth S; Issop Y; Cox D; Müller JS; Evangelista T; Stålberg E; Ioos C; Barois A; Brochier G; Sternberg D; Fournier E; Hantaï D; Abicht A; Dusl M; Laval SH; Griffin H; Eymard B; Lochmüller H
    Brain; 2014 Sep; 137(Pt 9):2429-43. PubMed ID: 24951643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital myasthenic syndromes: recent advances.
    Beeson D
    Curr Opin Neurol; 2016 Oct; 29(5):565-71. PubMed ID: 27472506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital Myasthenic Syndromes.
    Iyadurai SJP
    Neurol Clin; 2020 Aug; 38(3):541-552. PubMed ID: 32703467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and research strategies for limb-girdle congenital myasthenic syndromes.
    O'Connor E; Töpf A; Zahedi RP; Spendiff S; Cox D; Roos A; Lochmüller H
    Ann N Y Acad Sci; 2018 Jan; 1412(1):102-112. PubMed ID: 29315608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital Myasthenic Syndromes.
    Shieh PB; Oh SJ
    Neurol Clin; 2018 May; 36(2):367-378. PubMed ID: 29655455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital myasthenic syndromes and the formation of the neuromuscular junction.
    Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A
    Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
    Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
    Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.